Controlled-Release Systems for Ophthalmic Applications
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: 30 June 2024 | Viewed by 916
Special Issue Editors
Interests: ophthalmic; long-acting injectables; intrauterine systems; IVIVCs development; gold nanoparticles; complex drug products; formulation sciences
Interests: ophthalmic delivery: lipid nano particles, nano emulsions, inserts, films, in situ gels; glaucoma; keratitis; small molecules; biologics; oral delivery; drug product development
Special Issue Information
Dear Colleagues,
Ophthalmic dosage forms or ocular drug delivery systems face tremendous challenges ranging from drug delivery strategies, formulation, manufacturing, quality control and bioequivalence evaluation due to the complex anatomy of human eyes. In addition, most of the ophthalmic route of administration is for local drug delivery; therefore, the commonly used pharmacokinetic approach is not sufficient to evaluate the absorption of these formulations. Over the past several decades, efforts have been made to improve the bioavailability of the ophthalmic formulations through controlled or sustained drug delivery strategies such as implants (intraocular or intravitreal), long-acting injectable suspensions, and ophthalmic gels. This Special Issue will focus on the controlled or sustained drug delivery of both small and large molecules for ophthalmic application. Both comprehensive reviews and research manuscripts in this area are welcome.
We look forward to receiving your contributions.
Dr. Quanying Bao
Dr. Narendar Dudhipala
Dr. Laibin Luo
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- controlled release
- ophthalmic
- drug delivery
- intravitreal
- implants
- gels
